Literature DB >> 30315815

The role of telomere shortening in carcinogenesis: A hybrid stochastic-deterministic approach.

Ignacio A Rodriguez-Brenes1, Natalia L Komarova2, Dominik Wodarz2.   

Abstract

Genome instability is a characteristic of most cancers, contributing to the acquisition of genetic alterations that drive tumor progression. One important source of genome instability is linked to telomere dysfunction in cells with critically short telomeres that lack p53-mediated surveillance of genomic integrity. Here we research the probability that cancer emerges through an evolutionary pathway that includes a telomere-induced phase of genome instability. To implement our models we use a hybrid stochastic-deterministic approach, which allows us to perform large numbers of simulations using biologically realistic population sizes and mutation rates, circumventing the traditional limitations of fully stochastic algorithms. The hybrid methodology should be easily adaptable to a wide range of evolutionary problems. In particular, we model telomere shortening and the acquisition of two mutations: Telomerase activation and p53 inactivation. We find that the death rate of unstable cells, and the number of cell divisions that p53 mutants can sustain beyond the normal senescence setpoint determine the likelihood that the first double mutant originates in a cell with telomere-induced instability. The model has applications to an influential telomerase-null mouse model and p16 silenced human cells. We end by discussing algorithmic performance and a measure for the accuracy of the hybrid approximation.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Computational Evolution; Hybrid stochasticdeterministic methods; Telomeres

Mesh:

Substances:

Year:  2018        PMID: 30315815      PMCID: PMC6234035          DOI: 10.1016/j.jtbi.2018.09.003

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  42 in total

1.  Efficient step size selection for the tau-leaping simulation method.

Authors:  Yang Cao; Daniel T Gillespie; Linda R Petzold
Journal:  J Chem Phys       Date:  2006-01-28       Impact factor: 3.488

2.  Cancer-associated mutations in healthy individuals: assessing the risk of carcinogenesis.

Authors:  Ignacio A Rodriguez-Brenes; Natalia L Komarova; Dominik Wodarz
Journal:  Cancer Res       Date:  2014-01-22       Impact factor: 12.701

3.  Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia.

Authors:  Charles R Holst; Gerard J Nuovo; Manel Esteller; Karen Chew; Stephen B Baylin; James G Herman; Thea D Tlsty
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

Review 4.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

5.  Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse.

Authors:  R A Greenberg; L Chin; A Femino; K H Lee; G J Gottlieb; R H Singer; C W Greider; R A DePinho
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

6.  Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.

Authors:  K L Rudolph; M Millard; M W Bosenberg; R A DePinho
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

7.  Significant role for p16INK4a in p53-independent telomere-directed senescence.

Authors:  Jacqueline J L Jacobs; Titia de Lange
Journal:  Curr Biol       Date:  2004-12-29       Impact factor: 10.834

Review 8.  Senescence and immortalization: role of telomeres and telomerase.

Authors:  Jerry W Shay; Woodring E Wright
Journal:  Carcinogenesis       Date:  2004-10-07       Impact factor: 4.944

9.  Breast primary epithelial cells that escape p16-dependent stasis enter a telomere-driven crisis state.

Authors:  Purificación Feijoo; Mariona Terradas; David Soler; Daniel Domínguez; Laura Tusell; Anna Genescà
Journal:  Breast Cancer Res       Date:  2016-01-13       Impact factor: 6.466

10.  Quantifying replicative senescence as a tumor suppressor pathway and a target for cancer therapy.

Authors:  Ignacio A Rodriguez-Brenes; Dominik Wodarz; Natalia L Komarova
Journal:  Sci Rep       Date:  2015-12-09       Impact factor: 4.379

View more
  2 in total

Review 1.  The 2019 mathematical oncology roadmap.

Authors:  Russell C Rockne; Andrea Hawkins-Daarud; Kristin R Swanson; James P Sluka; James A Glazier; Paul Macklin; David A Hormuth; Angela M Jarrett; Ernesto A B F Lima; J Tinsley Oden; George Biros; Thomas E Yankeelov; Kit Curtius; Ibrahim Al Bakir; Dominik Wodarz; Natalia Komarova; Luis Aparicio; Mykola Bordyuh; Raul Rabadan; Stacey D Finley; Heiko Enderling; Jimmy Caudell; Eduardo G Moros; Alexander R A Anderson; Robert A Gatenby; Artem Kaznatcheev; Peter Jeavons; Nikhil Krishnan; Julia Pelesko; Raoul R Wadhwa; Nara Yoon; Daniel Nichol; Andriy Marusyk; Michael Hinczewski; Jacob G Scott
Journal:  Phys Biol       Date:  2019-06-19       Impact factor: 2.959

2.  A hybrid stochastic-deterministic approach to explore multiple infection and evolution in HIV.

Authors:  Jesse Kreger; Natalia L Komarova; Dominik Wodarz
Journal:  PLoS Comput Biol       Date:  2021-12-22       Impact factor: 4.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.